GI CONNECT has summarised the highlights of the ASCO GI 2015 meeting in San Francisco for you.
Cancers of the Upper GI Tract by Dr Stintzing
GI CONNECT has summarised the highlights of the ASCO GI 2015 meeting in San Francisco for you.
Cancers of the Upper GI Tract by Dr Stintzing
Sebastian Stintzing (M.D.), Professor of Medicine, is Head of the Division of Oncology and Haematology, Department of Medicine (CCM), Charité Universitaetsmedizin Berlin. His research focuses on predictive and prognostic biomarkers in the treatment of GI cancer with a special focus on colorectal cancer. From 2012 to 2014, he was a research fellow at the Sharon Carpenter Laboratory at the University of Southern California Norris Comprehensive Cancer Center, Los Angeles, U.S.A. He coordinated the translational part and assisted the clinical study conduct of several studies and earned his Postdoctoral Lecture Qualification with a thesis on prognostic and predictive factors in the treatment of metastatic colorectal cancer. In 2012, he received the prestigious Research Fellowship Award from the German Cancer Aid in Germany and started work at the University of Southern California. Dr Stintzing is member of national and international cancer associations and speaker of the steering committee of the working group Colorectal Carcinoma of the German AIO.
AMGEN, AstraZeneca, Bayer, BMS, CV6, Eisai, Isofol, Lilly, Merck KGaA, MSD, Pierre Fabre, Roche, Sanofi, Taiho, Takeda
Findings from a global survey presented in a poster at ESMO 2024
Renowned medical experts share their insights into new data presented at ESMO 2024
From sample collection through to diagnostic modalities
A 3-part video series on managing early RRMM from leading medical experts
Recommendations for best practice